-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DXWiosBF3Xt7KSs7F0LLZmShyDj8sCbC/iDDaV9+z0VfYrYnA2wFI9WfnvE1O8QI A57yH7hDw1jJhaxWnWLBrw== 0000700859-07-000033.txt : 20071030 0000700859-07-000033.hdr.sgml : 20071030 20071030161120 ACCESSION NUMBER: 0000700859-07-000033 CONFORMED SUBMISSION TYPE: N-Q PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20070831 FILED AS OF DATE: 20071030 DATE AS OF CHANGE: 20071030 EFFECTIVENESS DATE: 20071030 FILER: COMPANY DATA: COMPANY CONFORMED NAME: FIDELITY SECURITIES FUND CENTRAL INDEX KEY: 0000754510 IRS NUMBER: 000000000 FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: N-Q SEC ACT: 1940 Act SEC FILE NUMBER: 811-04118 FILM NUMBER: 071199720 BUSINESS ADDRESS: STREET 1: 82 DEVONSHIRE ST STREET 2: MAILZONE Z1C CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 6174391706 MAIL ADDRESS: STREET 1: 82 DEVONSHIRE STREET STREET 2: MAILZONE Z1C CITY: BOSTON STATE: MA ZIP: 02109 0000754510 S000007190 Advisor Agressive Growth Fund C000019674 Class A FGVAX C000019675 Class B FGVBX C000019676 Class C FGECX C000019677 Class T FGVTX C000019678 Institutional Class FRVIX N-Q 1 main.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM N-Q

QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY

Investment Company Act file number 811-4118

Fidelity Securities Fund
(Exact name of registrant as specified in charter)

82 Devonshire St., Boston, Massachusetts 02109
(Address of principal executive offices) (Zip code)

Eric D. Roiter, Secretary

82 Devonshire St.

Boston, Massachusetts 02109
(Name and address of agent for service)

Registrant's telephone number, including area code: 617-563-7000

Date of fiscal year end:

November 30

Date of reporting period:

August 31, 2007

Item 1. Schedule of Investments

Quarterly Holdings Report

for

Fidelity ® Advisor Aggressive
Growth Fund
Class A
Class T
Class B
Class C
Institutional Class

August 31, 2007

1.805754.103

AAG-QTLY-1007

Investments August 31, 2007 (Unaudited)

Showing Percentage of Net Assets

Common Stocks - 98.8%

Shares

Value

CONSUMER STAPLES - 1.8%

Food Products - 1.8%

Marine Harvest ASA (a)

268,000

$ 314,461

Tyson Foods, Inc. Class A

25,100

540,905

855,366

ENERGY - 7.9%

Energy Equipment & Services - 1.3%

FMC Technologies, Inc. (a)

6,700

634,490

Oil, Gas & Consumable Fuels - 6.6%

Denbury Resources, Inc. (a)

14,598

580,708

Gulfport Energy Corp. (a)

13,408

241,478

Quicksilver Resources, Inc. (a)

13,658

545,637

Range Resources Corp.

16,350

593,669

Valero Energy Corp.

7,400

506,974

Williams Companies, Inc.

24,155

748,805

3,217,271

TOTAL ENERGY

3,851,761

FINANCIALS - 14.1%

Capital Markets - 3.9%

Indiabulls Financial Services Ltd.

69,055

912,039

T. Rowe Price Group, Inc.

19,549

1,003,255

1,915,294

Commercial Banks - 1.1%

Commerce Bancorp, Inc.

14,200

521,566

Diversified Financial Services - 5.9%

CME Group, Inc.

900

499,320

Deutsche Boerse AG

8,800

971,083

IntercontinentalExchange, Inc. (a)

3,500

510,545

JSE Ltd.

40,916

407,153

MarketAxess Holdings, Inc. (a)

13,587

236,821

NYMEX Holdings, Inc.

2,000

258,040

2,882,962

Real Estate Management & Development - 3.2%

Dev Property Development PLC

177,000

267,710

Indiabulls Real Estate Ltd. (a)

104,925

1,276,063

1,543,773

TOTAL FINANCIALS

6,863,595

Common Stocks - continued

Shares

Value

HEALTH CARE - 28.6%

Biotechnology - 5.3%

Alnylam Pharmaceuticals, Inc. (a)

36,600

$ 855,342

Amylin Pharmaceuticals, Inc. (a)

9,429

462,304

CytRx Corp. (a)

81,318

294,372

Omrix Biopharmaceuticals, Inc. (a)

13,127

459,576

ONYX Pharmaceuticals, Inc. (a)

12,678

502,302

2,573,896

Health Care Equipment & Supplies - 17.1%

ArthroCare Corp. (a)

11,652

652,745

Conceptus, Inc. (a)

22,634

396,095

Cyberonics, Inc. (a)

33,972

512,637

Hologic, Inc. (a)

19,378

1,029,941

NeuroMetrix, Inc. (a)

15,606

121,259

Northstar Neuroscience, Inc. (a)

24,083

273,583

NuVasive, Inc. (a)

43,200

1,378,080

Respironics, Inc. (a)

10,100

479,043

St. Jude Medical, Inc. (a)

79,600

3,468,169

8,311,552

Health Care Technology - 3.0%

Allscripts Healthcare Solutions, Inc. (a)

11,600

262,276

Cerner Corp. (a)

9,320

531,613

Eclipsys Corp. (a)

10,217

235,911

Merge Technologies, Inc. (a)

39,705

185,819

Vital Images, Inc. (a)

11,900

220,626

1,436,245

Life Sciences Tools & Services - 1.4%

AMAG Pharmaceuticals, Inc.

12,596

688,371

Pharmaceuticals - 1.8%

Allergan, Inc.

9,700

582,097

Collagenex Pharmaceuticals, Inc. (a)

23,483

301,052

883,149

TOTAL HEALTH CARE

13,893,213

INDUSTRIALS - 11.4%

Air Freight & Logistics - 1.1%

Panalpina Welttransport Holding AG

2,860

508,665

Common Stocks - continued

Shares

Value

INDUSTRIALS - continued

Commercial Services & Supplies - 1.2%

Clean Harbors, Inc. (a)

5,200

$ 245,388

CoStar Group, Inc. (a)

6,373

350,706

596,094

Construction & Engineering - 5.9%

Granite Construction, Inc.

11,300

615,172

Quanta Services, Inc. (a)

79,301

2,241,839

2,857,011

Electrical Equipment - 1.6%

Neo-Neon Holdings Ltd.

140,000

273,633

Prysmian SpA

20,500

509,550

783,183

Machinery - 1.1%

Bucyrus International, Inc. Class A

8,600

537,414

Marine - 0.5%

Ultrapetrol (Bahamas) Ltd.

14,181

255,542

TOTAL INDUSTRIALS

5,537,909

INFORMATION TECHNOLOGY - 32.8%

Communications Equipment - 4.4%

Adtran, Inc.

22,523

602,040

Infinera Corp.

2,800

53,928

Juniper Networks, Inc. (a)

29,400

967,848

Polycom, Inc. (a)

16,500

500,115

2,123,931

Computers & Peripherals - 1.9%

Network Appliance, Inc. (a)

9,300

259,098

SanDisk Corp. (a)

11,852

664,423

923,521

Internet Software & Services - 4.4%

Digital River, Inc. (a)

5,000

231,800

Omniture, Inc. (a)

19,843

492,305

SAVVIS, Inc. (a)

17,035

676,801

ValueClick, Inc. (a)

35,900

719,436

2,120,342

IT Services - 6.3%

BearingPoint, Inc. (a)

3,000

17,610

Mastercard, Inc. Class A

16,731

2,291,980

Common Stocks - continued

Shares

Value

INFORMATION TECHNOLOGY - continued

IT Services - continued

Redecard SA

16,700

$ 255,352

Unisys Corp. (a)

69,400

511,478

3,076,420

Semiconductors & Semiconductor Equipment - 13.3%

Advanced Micro Devices, Inc. (a)

57,300

744,900

Altera Corp.

21,463

511,034

Broadcom Corp. Class A (a)

41,979

1,448,276

Hittite Microwave Corp. (a)

13,142

556,827

Marvell Technology Group Ltd. (a)

87,900

1,456,503

PMC-Sierra, Inc. (a)

160,993

1,236,426

Xilinx, Inc.

20,000

511,400

6,465,366

Software - 2.5%

Financial Technology (India) Ltd.

6,552

396,885

Quality Systems, Inc.

6,341

233,666

Synchronoss Technologies, Inc. (a)

17,560

610,034

1,240,585

TOTAL INFORMATION TECHNOLOGY

15,950,165

TELECOMMUNICATION SERVICES - 1.8%

Diversified Telecommunication Services - 1.8%

Time Warner Telecom, Inc. Class A (sub. vtg.) (a)

39,900

875,805

UTILITIES - 0.4%

Independent Power Producers & Energy Traders - 0.4%

Ocean Power Technologies, Inc. (a)

14,248

178,100

TOTAL COMMON STOCKS

(Cost $44,838,141)

48,005,914

Money Market Funds - 1.6%

Shares

Value

Fidelity Cash Central Fund, 5.48% (b)
(Cost $780,198)

780,198

$ 780,198

TOTAL INVESTMENT PORTFOLIO - 100.4%

(Cost $45,618,339)

48,786,112

NET OTHER ASSETS - (0.4)%

(209,707)

NET ASSETS - 100%

$ 48,576,405

Legend

(a) Non-income producing

(b) Affiliated fund that is available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request.

Affiliated Central Funds

Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:

Fund

Income earned

Fidelity Cash Central Fund

$ 25,778

Fidelity Securities Lending Cash Central Fund

9,756

Total

$ 35,534

Income Tax Information

At August 31, 2007, the aggregate cost of investment securities for income tax purposes was $46,167,606. Net unrealized appreciation aggregated $2,618,506, of which $6,310,340 related to appreciated investment securities and $3,691,834 related to depreciated investment securities.

Investment Valuation

Investments are valued as of the close of business of the New York Stock Exchange (NYSE), normally 4:00 p.m. Eastern time. Security transactions are accounted for as of trade date. Wherever possible, the fund uses independent pricing services approved by the Board of Trustees to value its investments. Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by an independent pricing service on the primary market or exchange on which they are traded. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price. Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day. Short-term securities with remaining maturities of sixty days or less for which quotations are not readily available are valued at amortized cost, which approximates value. When current market prices or quotations are not readily available or do not accurately reflect fair value, valuations may be determined in accordance with procedures adopted by the Board of Trustees. For example, when developments occur between the close of a market and the close of the NYSE that may materially affect the value of some or all of the securities, or when trading in a security is halted, those securities may be fair valued. The frequency of when fair value pricing is used is unpredictable. The value of securities used under fair value pricing may differ from published prices for the same securities.

For additional information on the fund's policy regarding valuation of investments and other significant accounting policies, please refer to the fund's most recent semiannual or annual shareholder report.

Quarterly Report

The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please visit advisor.fidelity.com or call Fidelity at 1-877-208-0098 for a free copy of the fund's most recent prospectus and annual report.

Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.

Quarterly Report

Item 2. Controls and Procedures

(a)(i) The President and Treasurer and the Chief Financial Officer have concluded that the Fidelity Securities Fund's (the "Trust") disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act) provide reasonable assurances that material information relating to the Trust is made known to them by the appropriate persons, based on their evaluation of these controls and procedures as of a date within 90 days of the filing date of this report.

(a)(ii) There was no change in the Trust's internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act) that occurred during the Trust's last fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Trust's internal control over financial reporting.

Item 3. Exhibits

Certification pursuant to Rule 30a-2(a) under the Investment Company Act of 1940 (17 CFR 270.30a-2(a)) is filed and attached hereto as Exhibit 99.CERT.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Fidelity Securities Fund

By:

/s/Kimberley Monasterio

Kimberley Monasterio

President and Treasurer

Date:

October 30, 2007

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

By:

/s/ Kimberley Monasterio

Kimberley Monasterio

President and Treasurer

Date:

October 30, 2007

By:

/s/Joseph B. Hollis

Joseph B. Hollis

Chief Financial Officer

Date:

October 30, 2007

EX-99.CERT 2 sec99cert.htm

Exhibit EX-99.CERT

I, Kimberley Monasterio, certify that:

1. I have reviewed this report on Form N-Q of Fidelity Securities Fund;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based upon such evaluation; and

d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: October 30, 2007

/s/Kimberley Monasterio

Kimberley Monasterio

President and Treasurer

I, Joseph B. Hollis, certify that:

1. I have reviewed this report on Form N-Q of Fidelity Securities Fund;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based upon such evaluation; and

d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: October 30, 2007

/s/Joseph B. Hollis

Joseph B. Hollis

Chief Financial Officer

-----END PRIVACY-ENHANCED MESSAGE-----